ArticleFrontiers in oncology2025
Artificial intelligence-based magnetic resonance imaging for preoperative staging of patients with endometrial cancer: a systematic review and meta-analysis.
Article in Frontiers in oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: To systematically collect all literature on the value of artificial intelligence (AI)-based magnetic resonance imaging (MRI) for preoperative prediction of myometrial invasion and cervical stroma invasion in patients with endometrial cancer and conduct a meta-analysis to provide the latest and most comprehensive synthesis of current research findings. Methods: A systematic literature search was conducted in PubMed, Web of Science, Embase, and the Cochrane Library databases up to March 2025. The methodological quality of the included studies was assessed using the QUADAS-2 tool. Statistical analyses were primarily conducted using Stata15.0 and Review Manager 5.4.1 software. Outcomes included combined Sen, Spe, +LR, -LR, DOR, and their 95% CI. The SROC curve was plotted, and the AUC was calculated. The Deeks' funnel plot was used to detect publication bias and assumed small-study effects. Results: Finally, 8 studies (including 13 cohorts) were included. The overall performance of AI-based MRI for the prediction of deep myometrial invasion showed a combined Sen, Spe, +LR, -LR, DOR, and AUC value of 0.80 (95% CI: 0.75-0.85), 0.81 (95% CI: 0.64-0.91), 4.2 (95% CI: 2.0-8.5), 0.24 (95% CI: 0.17-0.34), 17 (95% CI: 6-47), and 0.83 (95% CI: 0.80-0.86), respectively. The overall performance of AI-based MRI for the prediction of cervical stroma invasion showed a combined Sen, Spe, +LR, -LR, DOR, and AUC value of 0.78 (95% CI: 0.55-0.91), 0.86 (95% CI: 0.79-0.91), 5.6 (95% CI: 4.3-7.4), 0.25 (95% CI: 0.12-0.55), 22 (95% CI: 11-44), and 0.90 (95% CI: 0.87-0.92) respectively. Conclusion: AI-based MRI can improve the accuracy of preoperative staging of patients with endometrial cancer to a certain extent. However, considering the limitations of this article, additional large-scale, prospective, multicenter clinical trials are necessary to further investigate the utility of AI-based MRI in the preoperative staging of endometrial cancer.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.